Eli Lilly loses appeal to overturn $183.7M Medicaid fraud award


Indianapolis - April 2016: Eli Lilly and Company V

jetcityimage/iStock Editorial via Getty Images

Eli Lilly (NYSE:LLY) must pay $183.7M as damages in a lawsuit alleging that the Indiana-based drugmaker defrauded the Medicaid drug pricing program, a federal appeals court ruled on Thursday, upholding a lower court ruling.

In August 2022, a federal jury ordered



Source link

Color grade like Annie Leibovitz

Supporters Believe Charlie Kirk’s Wife Is Pregnant With her Third Child

Leave a Reply

Your email address will not be published. Required fields are marked *